Methods and Systems for Increased Production of Stem Cells
OwnerTodd Frank Ovokaitysinventor
Life of this patent
Estimating the term…
Abstract
Platelet rich plasma containing human very small embryonic-like stem cells (hVSEL) is treated with amplitude-modulated pulses of laser light having a predefined wavelength for a predefined time period, where the predefined wavelength ranges from 300 nm to 1000 nm. Treatment of the platelet rich plasma using this method results in an unexpectedly high degree of proliferation of the hVSEL in the platelet rich plasma, resulting in reduction of biological age, when administered to a patient.
Claims27
A method of reducing biological age of a patient comprising:
- proliferating stem cells of the patient, wherein the proliferation comprises preparing platelet rich plasma containing stem cells and treating the platelet rich plasma containing stem cells with modulated pulses of laser light having a predefined wavelength and for a predefined period of time;
- and,
- administering the treated platelet rich plasma to the patient.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of reducing biological age of a patient comprising:
- proliferating stem cells of the patient, comprising:
- adding normal human blood into a plurality of tubes;
- centrifuging the plurality of tubes at a predefined g force for 10 minutes to produce platelet rich plasma;
- shaking the plurality of tubes;
- aliquoting the produced platelet rich plasma into a sterile tube;
- shaking the platelet rich plasma in the sterile tube;
- treating the platelet rich plasma with modulated pulses of laser light having a predefined wavelength and for a predefined period of time;
- and
- shaking the treated platelet rich plasma;
- and,
- administering the treated platelet rich plasma to the patient.
(canceled)
(canceled)
Dependencies are inferred from the claim text.